Research Analysts Set Expectations for Bruker Q1 Earnings

Bruker Co. (NASDAQ:BRKR) – Investment analysts at Zacks Research reduced their Q1 2025 earnings per share (EPS) estimates for shares of Bruker in a report released on Thursday, March 6th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $0.44 per share for the quarter, down from their previous forecast of $0.52. The consensus estimate for Bruker’s current full-year earnings is $2.69 per share. Zacks Research also issued estimates for Bruker’s Q3 2025 earnings at $0.70 EPS, FY2025 earnings at $2.67 EPS, Q2 2026 earnings at $0.70 EPS, Q3 2026 earnings at $0.82 EPS, FY2026 earnings at $3.11 EPS and FY2027 earnings at $3.60 EPS.

A number of other equities research analysts have also issued reports on BRKR. Barclays reduced their target price on Bruker from $69.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Bank of America upped their target price on Bruker from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Friday, December 13th. The Goldman Sachs Group raised Bruker from a “sell” rating to a “neutral” rating and set a $60.00 target price on the stock in a research note on Thursday, December 5th. Stifel Nicolaus reduced their target price on Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research note on Friday, February 14th. Finally, Guggenheim reissued a “buy” rating on shares of Bruker in a research note on Monday, February 24th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Bruker presently has a consensus rating of “Moderate Buy” and a consensus price target of $70.50.

Bruker Stock Performance

BRKR opened at $48.41 on Friday. The stock has a market cap of $7.34 billion, a P/E ratio of 63.70, a P/E/G ratio of 2.16 and a beta of 1.16. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77. The stock’s 50 day simple moving average is $55.17 and its 200 day simple moving average is $59.20. Bruker has a 1-year low of $45.29 and a 1-year high of $94.86.

Bruker (NASDAQ:BRKR) last released its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Retirement Systems of Alabama grew its position in Bruker by 11.7% during the 3rd quarter. Retirement Systems of Alabama now owns 134,254 shares of the medical research company’s stock worth $9,272,000 after purchasing an additional 14,069 shares in the last quarter. Cerity Partners LLC lifted its stake in shares of Bruker by 446.8% in the 3rd quarter. Cerity Partners LLC now owns 27,998 shares of the medical research company’s stock valued at $1,934,000 after purchasing an additional 22,878 shares during the last quarter. Merit Financial Group LLC acquired a new stake in shares of Bruker in the 4th quarter valued at $300,000. Brown Brothers Harriman & Co. lifted its stake in shares of Bruker by 39.9% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 602,144 shares of the medical research company’s stock valued at $41,584,000 after purchasing an additional 171,806 shares during the last quarter. Finally, FMR LLC lifted its stake in shares of Bruker by 21.4% in the 3rd quarter. FMR LLC now owns 14,306,122 shares of the medical research company’s stock valued at $987,981,000 after purchasing an additional 2,521,904 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company’s stock.

Bruker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Monday, March 17th will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, March 17th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.41%. Bruker’s dividend payout ratio is presently 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.